Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Dr. Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Dr. Tong Qiao | Medicine and Health Sciences | Head of ophthalmology at Shanghai Jiao Tong University | ChinaΒ 

Dr. Tong Qiao is a distinguished clinician-scientist in pediatric ophthalmology with extensive expertise in the diagnosis and management of complex childhood eye disorders. She completed her foundational medical training with a Bachelor of Medicine, followed by a Master of Medicine, and later earned a Doctor of Philosophy in medicine from leading academic institutions in China, establishing a strong academic and clinical foundation in ophthalmology. Dr. Tong Qiao has authored 35 scholarly documents, received 343 citations, and maintains a 9 h-index, reflecting consistent academic influence and international research visibility in indexed scientific literature. Her publication record includes contributions to reputable, peer-reviewed journals, supporting evidence-based advancements in pediatric ophthalmology and visual sciences.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
343

Documents
35

h-index
9

🟦 CitationsΒ  Β  Β  Β πŸŸ₯ DocumentsΒ  Β   🟩 h-index


View Scopus Profile

Featured Publications

Digital measurement of pupil size, corneal size, and eccentricity in Guinea pigs using Python compared with traditional OCT
– Scientific Reports, Open Access
Bilateral superior oblique suture extension in pediatric A-pattern esotropia
– Medical Hypothesis Discovery and Innovation in Ophthalmology, Open Access
Surgical treatment and levator muscle protein analysis of congenital ptosis in craniosynostosis: A case-control study
– Medicine, Open Access

Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award | Pharmaceutical | Abdul Wali Khan University Mardan | Pakistan

Dr. Muhammad Bilal Afridi is a dedicated pharmaceutical scientist and clinical pharmacist recognized for his expertise in drug synthesis, pharmacological modeling, and computational chemistry. With a profound academic background and more than a decade of professional experience, Dr. Afridi has established himself as a leading researcher in the domain of synthetic and therapeutic drug development. He earned his Ph.D. in Pharmaceutical Sciences from Abdul Wali Khan University, Mardan, where his doctoral research focused on the synthesis, characterization, computational studies, and pharmacological potential of synthetic curcumin derivatives aimed at addressing diabetes and amnesia-related disorders. His earlier academic milestones include an M.Phil in Pharmaceutical Sciences from Abdul Wali Khan University and a Doctor of Pharmacy (Pharm-D) from Kohat University of Science and Technology. Professionally, Dr. Muhammad Bilal Afridi has served as a pharmacist at the Institute of Kidney Diseases (IKD), Peshawar, where he managed hospital pharmacy operations, clinical pharmacy services, and patient safety programs. His leadership extended to training junior pharmacists, supervising pharmacy interns, and participating in institutional Drug and Therapeutic Committees. His previous tenures at Rehman Medical Institute and D. Watson Chemist allowed him to develop robust skills in patient counseling, prescription review, pharmacovigilance, and rational drug use. Dr. Afridi’s research interests encompass computational drug design, molecular docking, pharmacodynamics, and synthesis of bioactive compounds, reflecting his interdisciplinary approach that bridges chemistry, pharmacology, and computational biology. His published works in highly regarded journals, including Computational Biology and Chemistry, Inorganic Chemistry Communications, and Current Molecular Pharmacology, contribute significantly to advancing medicinal chemistry and pharmaceutical innovation. He has demonstrated strong analytical and technical skills in density functional theory (DFT) modeling, ADMET prediction, and spectral analysis. Dr. Muhammad Bilal Afridi’s professional competencies include teaching, mentoring, research supervision, and scientific writing, backed by proficiency in tools like EndNote and MS Office. His contributions have been acknowledged through multiple peer-reviewed publications, collaborations with international researchers from TΓΌrkiye and Saudi Arabia, and recognition in academic circles for his commitment to scientific excellence. He continues to serve as a role model for young researchers in Pakistan through his dedication to patient-centered research and academic mentorship. His unwavering commitment to bridging pharmaceutical sciences and clinical applications makes him a strong candidate for recognition in global research excellence. Dr. Muhammad Bilal Afridi stands as an emerging leader with a promising future in international pharmaceutical research, committed to innovation, integrity, and impactful contributions to human health and medicine.

Profile: Scopus

Featured PublicationsΒ 

  1. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). SwissADME studies and density functional theory (DFT) approaches of methyl substituted curcumin derivatives. Computational Biology and Chemistry, 112, 108153. (Cited by 8)

  2. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives. Inorganic Chemistry Communications, 168, 112943. (Cited by 6)

  3. Afridi, M. B., Khan, H., Ali Shah, S. W., Zafar, M., Almalki, A. S., Ghias, M., & Rahman, N. (2022). In-vivo anti-nociceptive activities of Schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies. Main Group Chemistry, 21(2), 373–386. (Cited by 10)

  4. Afridi, M. B., Khan, H., Akkol, E. K., & Aschner, M. (2021). Pain perception and management: Where do we stand? Current Molecular Pharmacology, 14(5), 678–688. (Cited by 25)

  5. Afridi, M. B., Sardar, H., Shah, S. W. A., Serdaroğlu, G., & Khan, H. (2025). Exploring anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives. European Journal of Pharmacology, 950, 182653. (Cited by 2)

  6. Afridi, M. B., Khan, H., & Shah, S. W. A. (2023). Computational evaluation of synthetic curcumin analogs for neuroprotective potential using molecular docking approaches. Journal of Molecular Structure, 1287, 135623. (Cited by 4)

  7. Afridi, M. B., Sardar, H., & Khan, H. (2023). Pharmacological insights into curcumin derivatives: A computational and experimental perspective. Bioorganic Chemistry, 137, 106707. (Cited by 3)

 

Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Katarzyna Madziarska | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences | Head of Department | Wroclaw Medical University | Poland

Assoc. Prof. Dr. Katarzyna Madziarska is a distinguished Polish clinician-scientist, educator, and researcher whose career has been dedicated to advancing the fields of diabetology, nephrology, and internal medicine through outstanding academic leadership, clinical practice, and research excellence. She obtained her MD and PhD from Wroclaw Medical University, where she currently serves as Head of the Clinical Department of Diabetology, Hypertension, and Internal Diseases, a position that allows her to combine patient care with cutting-edge research and medical education. Her professional experience spans decades, including roles as resident, assistant, senior assistant, adjunct, and ultimately associate professor, giving her a comprehensive understanding of clinical and academic medicine. She has been actively involved in postgraduate medical training and serves as a coordinator for trainees, a member of doctoral and habilitation committees, and a lecturer at both undergraduate and postgraduate levels. Her research interests are focused on micro- and macrovascular complications of diabetes, diabetic nephropathy, chronic kidney disease, transplantology, and the long-term health consequences of COVID-19. She has authored 112 documents, 1,076 citations, and 15 h-index, demonstrating her sustained scientific output and influence within the international medical community. Her research skills include designing and coordinating clinical trials (Phase III and IV) as a principal investigator and national coordinator, reviewing manuscripts for international journals, supervising PhD theses, and managing multi-disciplinary research projects like the COLOS study on COVID-19 outcomes. She is also experienced in translational research linking immunological, metabolic, and renal parameters to improve clinical practice. Assoc. Prof. Dr. Katarzyna Madziarska is an active member of prestigious professional bodies such as the Polish Society of Nephrology (President of the Lower Silesia Branch), Polish Society of Diabetology (Board Member), and the Polish Academy of Sciences Clinical Sciences Committee, where she contributes to advancing healthcare policy and scientific development. Her organizational contributions include serving on the Senate and Faculty Council of Medical Sciences at Wroclaw Medical University, membership in the Bioethics Committee, and participation in the Scientific Council for Clinical Trials, demonstrating her commitment to institutional governance and ethical research conduct.

Profile :Β Β Scopus | ORCID

Featured Publications

  1. Diabetes Mellitus and Old Age – Risk Factors in Renal Replacement Therapy – 2020 – Citations: 48

  2. Evaluation of Immunological Parameters in Lipid Metabolism Disturbances in Primary Glomerulonephritis – 2019 – Citations: 35

  3. Microvascular and Macrovascular Complications in Diabetic Nephropathy: Clinical Predictors and Outcomes – 2021 – Citations: 62

  4. Post-COVID-19 Complications and Kidney Function: A Clinical Perspective – 2022 – Citations: 54

  5. Clinical Trials in Diabetes and Chronic Kidney Disease: Lessons from Multicenter Studies – 2023 – Citations: 39

  6. Role of Molecular Mechanisms in Homeostasis Regulation in Nephrology – 2020 – Citations: 42

 

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Published on by Research Hypothesis

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year πŸ† (Miller School of Medicine, 2015), the Outstanding Care Award πŸ… (Sarcoma Alliance, 2012), and the Leadership in Clinical Research πŸŽ–οΈ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

Jonathan Harley | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Jonathan Harley | Medicine and Health Sciences | Best Researcher Award

Mr Jonathan Harley, University of Minnesota Medical School, United States

Jonathan Harley πŸŽ“πŸ₯ is a dedicated medical student at the University of Cincinnati College of Medicine (M.D. anticipated 2026). He earned his B.A. in Mathematics summa cum laude (2021). Passionate about orthopaedic surgery, he is a Research Fellow at the University of Minnesota. His accolades include the Medical Student Research Award πŸ† and the Schiff Family Foundation Scholarship. A former collegiate athlete πŸƒβ€β™‚οΈ, he remains a competitive distance runner. He actively mentors students through Black Men in Medicine and SNMA. With numerous research presentations and professional memberships, he strives to impact sports medicine and patient care. πŸ”¬πŸ“šπŸ’ͺ

Publication Profile

Orcid

Education

Jonathan Harley is a dedicated medical student at the University of Cincinnati College of Medicine πŸŽ“πŸ©Ί, where he anticipates earning his M.D. in May 2026. He holds a Bachelor of Arts in Mathematics from the University of Cincinnati πŸŽ―πŸ“Š, graduating summa cum laude in May 2021 as part of the prestigious University Honors Program 🌟. With a strong analytical background and a passion for medicine πŸ’‘β€οΈ, Jonathan combines mathematical precision with compassionate healthcare. His journey reflects academic excellence, dedication, and a commitment to making a meaningful impact in the medical field. πŸš€πŸ₯

Experience

Jonathan Harley is a dedicated medical student pursuing a career in Orthopaedic Surgery πŸ₯🦴. Since June 2024, he has been the Orthopaedic Surgery Medical Student Research Fellow at the University of Minnesota Medical School’s Sports Medicine Division, working under renowned surgeons πŸ©ΊπŸ“Š. His role involves study creation, IRB submission, data collection, statistical analysis, and manuscript writing, focusing on shoulder arthroplasty and rotator cuff repair. Since June 2022, he has also been a Research Assistant at the University of Cincinnati, contributing to studies on ACL repair, opioid education, and geriatric hip fractures, with multiple abstracts and publications πŸ“šπŸ“ˆ.

Honors and Awards

Jonathan Harley πŸŽ“πŸ…, a distinguished medical student, has earned multiple accolades for his academic excellence and research contributions. He secured 3rd place in the 2022 Medical Student Research Award πŸ† at the University of Cincinnati College of Medicine’s Department of Orthopaedic Surgery. A Legion of Excellence Inductee (2021) πŸ…, he was recognized as the top senior student-athlete with the highest GPA. His achievements include the Schiff Family Foundation Endowed Scholarship πŸ’°, Connections Dual Admissions Program 🎟️, Dean’s List (8/8 Semesters) πŸ“œ, and the Cincinnatus Excellence Scholarship πŸŽ–οΈ, reflecting his dedication to medicine and academic success.

Presentations

Jonathan Harley πŸ₯ has actively contributed to orthopedic research through multiple podium and poster presentations. He presented a study on shoulder range of motion and ACL psychological readiness at the UCCOM Medical Student Summer Research Presentation (2022) 🎀. His poster presentations include research on opioid consumption after shoulder arthroplasty at the University of Minnesota Orthopaedic Surgery Research Symposium (2025) πŸ’Š, as well as findings on rotator cuff retear rates 🦾. Additionally, he has presented studies on shoulder range of motion at the UCCOM Research and Service Symposium (2022) πŸ“Š and the SNMA Region V Medical Education Conference πŸ“’.

Research Focus

Jonathan D. Harley’s research primarily focuses on orthopedic surgery, particularly in shoulder and knee injuries πŸ€•πŸ¦΅. His studies examine rotator cuff repair outcomes, postoperative pain management, and ligament and tendon injuries in athletes πŸ₯⚽. He investigates rehabilitation strategies, opioid consumption following anesthesia, and the biomechanics of joint recovery πŸ‹οΈβ€β™‚οΈπŸ”¬. His case reports highlight complex injuries, while his clinical research assesses surgical techniques and patient-reported outcomes πŸ“ŠπŸ©Ί. Through his contributions, Harley aims to enhance patient recovery, surgical efficacy, and sports injury management πŸš‘πŸ’‘. His work is valuable for sports medicine, orthopedic surgery, and rehabilitation sciences πŸ₯πŸ“š.

Publication Top Notes

Rates of Retear following Rotator Cuff Repair are Similar Between Men and Women

Early postoperative opioid consumption following liposomal bupivacaine compared to standard bupivacaine in interscalene brachial plexus block for shoulder arthroplasty

Concomitant Rupture of the Anterior Cruciate Ligament and the Patellar Tendon in a High-Level Athlete: A Case Report

A comparison of quantitative and qualitative shoulder range of motion with patient-reported outcomes